Mylan Denied Summary Judgment In Antitrust Case
A federal judge has refused Mylan Laboratories Inc.'s bid to dismiss claims related to the anti-anxiety drug lorazepam in a lawsuit alleging the drugmaker conspired with competitors to inflate drug prices....To view the full article, register now.
Already a subscriber? Click here to view full article